Navigation Links
Book: 'Synthetic Biology and Morality'
Date:9/12/2013

Synthetic biology aims to design and build organisms to serve human ends, such as producing inexpensive biofuels and developing new kinds of medicines. But this new form of biotechnology also raises ethical questions. The concerns range from environmental and public health risks to social and economic impact, but perhaps the foremost is, Should we be "creating life" in the first place?

The last question is explored in Synthetic Biology and Morality: Artificial Life and the Bounds of Nature, a collection of essays edited by Hastings Center scholars Gregory E. Kaebnick and Thomas H. Murray, just published by MIT Press.

"Synthetic biology seems to involve a quest for a degree of control over the basic mechanisms of life that human beings have never attained before; is that quest desirable? Is it troubling?" write Kaebnick and Murray in the introduction.

The book is the product of a Hastings Center project on synthetic biology that examined and debated the idea of synthesizing life. The first section of the book focuses on the human relationship to nature, with essays identifying basic questions about the ethics of making new organisms. The second section asks whether synthetic organisms, far from being morally troubling, might actually be intrinsically valuable. The last section concerns values and public policywhether and how intrinsic moral objections to synthetic biology might be integrated into policy-making and public discourse.

Gregory Kaebnick is research scholar at The Hastings Center and editor of the Hastings Center Report. Thomas Murray is President Emeritus of the Center and a senior research scholar. Kaebnick and Murray were principal investigators on two Hastings Center projects on synthetic biology.

"Synthetic biology is a hot topic and deserves ethical scrutiny, and this is one of the first volumes that attempts it," says Dale Jamieson, Director of Environmental Studies, New York University and author of Ethics and the Environment.

Jonathan D. Moreno, David and Lyn Silfen University Professor, University of Pennsylvania, calls the book "as innovative as synthetic biology itself."

Other contributors to the book are John Basl, assistant professor of philosophy at Bowling Green State University; Mark A. Bedau, professor of philosophy and humanities at Reed College; Joachim Boldt, assistant professor of medical ethics and the history of medicine at Freiburg University in Germany; John H. Evans, professor of sociology at the University of California, San Diego; Bruce Jennings, senior advisor at The Hastings Center and director of bioethics at the Center for Humans and Nature; Ben Larson, of the National Institutes of Health; Andrew Lustig, the inaugural holder of the Holmes Rolston III Chair in Religion and Science at Davidson College; Jon Mandle, professor of philosophy at University at Albany; Christopher J. Preston, philosophy teacher at the University of Montana; and Ronald Sandler, associate professor of philosophy and director of the Ethics Institute at Northeastern University.


'/>"/>

Contact: Susan Gilbert
gilberts@thehastingscenter.org
845-424-4040 x244
The Hastings Center
Source:Eurekalert

Related biology news :

1. MIT and Wilson Center receive NSF grant to develop synthetic biology research agenda
2. Synthetic biology research community grows significantly
3. Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies
4. Predictability: The brass ring for synthetic biology
5. Synthetic molecule first electricity-making catalyst to use iron to split hydrogen gas
6. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
7. Developing microbial cell factories by employing synthetic small regulatory RNAs
8. Oscillating gel gives synthetic materials the ability to speak
9. Synthetic and biological nanoparticles combined to produce new metamaterials
10. New report finds increase in media coverage of synthetic biology
11. Synthetic fuel could eliminate US need for crude oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... 11, 2016 Synaptics Incorporated (NASDAQ: SYNA ... announced that its ClearPad ® TouchView ™ ... two separate categories in the 8 th Annual ... Technology Breakthrough. The Synaptics ® TDDI solution enables ... chain, thinner devices, brighter displays and borderless designs. ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today provided an update on the ... District of Texas and announcing ... Inter Partes Re-examination ("IPR") proceedings that VTech and ... was initiated on only certain claims of two of ...
(Date:2/4/2016)... Brooklyn, NY (PRWEB) , ... February 04, 2016 , ... ... cuvettes for over 10 years. What sets them apart from other cuvette ... that is posted on their website. On top of this steady flow of ...
(Date:2/3/2016)... Feb. 3, 2016 Ascendis Pharma A/S (Nasdaq: ... applies its innovative TransCon technology to address significant unmet ... upcoming investor conference.Event:2016 Leerink Partners Global Healthcare Conference Location: ... Wednesday, February 10, 2016 Time:  , 11:55am EST ... --> An audio webcast of this event ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... of potential targets (epitopes) specific to misfolded, propagating strains of Amyloid beta involved ... monoclonal antibody therapeutics for Alzheimer’s. , Following on from the first misfolded Amyloid ...
Breaking Biology Technology: